240 related articles for article (PubMed ID: 24005145)
1. Key Opinion Leader (KOL) Consensus for actinic keratosis management in Italy: the AKTUAL Workshop.
Peserico A; Neri L; Calzavara Pinton P; Catricalà C; Pellacani G; Peris K; Pimpinelli N
G Ital Dermatol Venereol; 2013 Oct; 148(5):515-24. PubMed ID: 24005145
[No Abstract] [Full Text] [Related]
2. Solar keratoses: photodynamic therapy, cryotherapy, 5-fluorouracil, imiquimod, diclofenac, or what? Facts and controversies.
Schmitt AR; Bordeaux JS
Clin Dermatol; 2013; 31(6):712-7. PubMed ID: 24160275
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the Treatment Guidelines for Actinic Keratosis: A Critical Appraisal and Review.
Fleming P; Zhou S; Bobotsis R; Lynde C
J Cutan Med Surg; 2017; 21(5):408-417. PubMed ID: 28510496
[TBL] [Abstract][Full Text] [Related]
4. Physicians' opinions and clinical practice patterns for actinic keratosis management in Italy.
Peris K; Neri L; Calzavara Pinton P; Catricalà C; Pellacani G; Pimpinelli N; Peserico A
G Ital Dermatol Venereol; 2014 Apr; 149(2):185-92. PubMed ID: 24819638
[TBL] [Abstract][Full Text] [Related]
5. What's new in the treatment of actinic keratoses?
Frankel A; Goldenberg G
Cutis; 2011 Feb; 87(2):62-4. PubMed ID: 21416769
[No Abstract] [Full Text] [Related]
6. Methods and Results Report - Evidence and consensus-based (S3) Guidelines for the Treatment of Actinic Keratosis -International League of Dermatological Societies in cooperation with the European Dermatology Forum.
Werner RN; Jacobs A; Rosumeck S; Erdmann R; Sporbeck B; Nast A
J Eur Acad Dermatol Venereol; 2015 Nov; 29(11):e1-66. PubMed ID: 26350885
[No Abstract] [Full Text] [Related]
7. Actinic keratoses: past, present and future.
Fenske NA; Spencer J; Adam F
J Drugs Dermatol; 2010 May; 9(5 Suppl ODAC Conf Pt 1):s45-9. PubMed ID: 20518359
[TBL] [Abstract][Full Text] [Related]
8. Actinic keratosis: new concepts and therapeutic approaches for an ancestral condition.
Alomar A
Actas Dermosifiliogr; 2014 Nov; 105(9):809-12. PubMed ID: 25060321
[No Abstract] [Full Text] [Related]
9. Current therapies for actinic keratosis.
Dianzani C; Conforti C; Giuffrida R; Corneli P; di Meo N; Farinazzo E; Moret A; Magaton Rizzi G; Zalaudek I
Int J Dermatol; 2020 Jun; 59(6):677-684. PubMed ID: 32012240
[TBL] [Abstract][Full Text] [Related]
10. Current management of actinic keratoses.
Shoimer I; Rosen N; Muhn C
Skin Therapy Lett; 2010 May; 15(5):5-7. PubMed ID: 20505896
[TBL] [Abstract][Full Text] [Related]
11. [Diagnosis and treatment of actinic keratosis].
Isoherranen K; Koskenmies S; Overmark M; Ylitalo L; Saksela O; Pitkänen S
Duodecim; 2015; 131(9):863-70. PubMed ID: 26237885
[TBL] [Abstract][Full Text] [Related]
12. Actinic keratosis: do the numbers add up?
Stanger CB
Nurse Pract; 2009 Feb; 34(2):36-9. PubMed ID: 19155885
[No Abstract] [Full Text] [Related]
13. Ingenol Mebutate and the Treatment of Actinic Keratosis.
Heron CE; Feldman SR
J Drugs Dermatol; 2021 Jan; 20(1):102-104. PubMed ID: 33400406
[TBL] [Abstract][Full Text] [Related]
14. A review of actinic keratosis, skin field cancerisation and the efficacy of topical therapies.
Sinclair R; Baker C; Spelman L; Supranowicz M; MacMahon B
Australas J Dermatol; 2021 May; 62(2):119-123. PubMed ID: 32840870
[TBL] [Abstract][Full Text] [Related]
15. Actinic keratosis. Patient-based approaches to adverse event management.
Huang WW; Clark AR
Adv NPs PAs; 2010 Dec; 1(4):31-2, 34-5, 48-9. PubMed ID: 21319451
[No Abstract] [Full Text] [Related]
16. Italian guidelines and therapeutic algorithm for actinic keratoses.
Rossi R; Calzavara-Pinton PG; Giannetti A; Peserico A; Santucci M; Vena GA; Lotti T
G Ital Dermatol Venereol; 2009 Dec; 144(6):713-23. PubMed ID: 19907409
[TBL] [Abstract][Full Text] [Related]
17. Swiss clinical practice guidelines on field cancerization of the skin.
Hofbauer G; Anliker M; Boehncke WH; Brand C; Braun R; Gaide O; Hafner J; Hunger R; Itin P; Kaeuper G; Lautenschlager S; Mainetti C; Streit M
Swiss Med Wkly; 2014; 144():w14026. PubMed ID: 25539459
[TBL] [Abstract][Full Text] [Related]
18. PICATO (ingenol mebutate 0.015% and 0.05% gels): a novel treatment for actinic keratosis.
Abramovits W; Oquendo M; Vincent KD; Gupta AK
Skinmed; 2013; 11(2):111-5. PubMed ID: 23745230
[No Abstract] [Full Text] [Related]
19. [Actinic keratoses].
Stockfleth E; Terhorst D; Hauschild A; Zouboulis CC; Schlaeger M; Oster-Schmidt C; Diepgen T; Garbe C; Gollnick H; Korting C; Merk H; Sterry W; Kerl H; Berking C
J Dtsch Dermatol Ges; 2012 Dec; 10 Suppl 7():S1-23. PubMed ID: 23110516
[No Abstract] [Full Text] [Related]
20. Reexamination of field-directed therapy for actinic keratosis.
Rosen T
Cutis; 2012 Oct; 90(4):163-5. PubMed ID: 23259199
[No Abstract] [Full Text] [Related]
[Next] [New Search]
